CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Cash flows from operating activities:
Net (loss) income	$ (14,923)	$ 4,455	$ (1,826)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	11,516	7,052	7,059
Net realized loss (gain) upon sale of marketable securities	794	(3,179)	2,363
Net change in unrealized loss (gain) on investments held at fair value	9,641	(7,094)	(788)
Share based incentive compensation	55	102	102
Amortization of intangible lease assets and liabilities	6,362	5,526	5,120
Amortization of deferred financing costs	278	275	391
Straight line rent	112	(537)	(1,065)
Amortization of discount on note to affiliate	181	174	164
Changes in assets and liabilities:
Receivables, net	(522)	(281)	122
Accrued interest receivable net of accrued interest payable, CMBS Trust	(13)	0	0
Deferred leasing costs	(365)	(400)	(909)
Prepaid and other assets	(316)	(77)	(59)
Accounts payable and accrued expenses	272	720	70
Other liabilities	(97)	114	(100)
Due to affiliates	(6,000)	6,156	(1,072)
Net cash provided by operating activities	6,975	13,006	9,572
Cash flows from investing activities:
Investment in real estate and related assets	0	(127,909)	0
Improvements to real estate assets	(2,264)	(1,387)	(2,004)
Investment in marketable securities	(33,529)	(26,403)	(25,250)
Proceeds from sale of marketable securities	32,549	20,230	24,572
Purchase of investment in CMBS Trust	(30,944)	0	0
Principal payments received from mortgage loans held in consolidated CMBS Trust	39	0	0
Net cash used in investing activities	(34,149)	(135,469)	(2,682)
Cash flows from financing activities:
Proceeds from line of credit	49,000	59,500	13,000
Repayment of line of credit	(46,500)	(55,700)	(16,100)
Proceeds from mortgage loans payable	0	66,000	0
Repayment of mortgage loans payable	(718)	(503)	(262)
Distribution of principal payments to bondholders of consolidated CMBS Trust	(39)	0	0
Proceeds from issuance of common stock	64,657	74,094	30,284
Payment of financing costs	0	(438)	0
Payment of offering costs	(3,788)	(2,731)	(3,205)
Distributions to investors	(8,403)	(6,221)	(5,342)
Redemption of common stock	(28,969)	(8,540)	(25,366)
Net cash provided by (used in) financing activities	25,240	125,461	(6,991)
Net (decrease) increase in cash and cash equivalents	(1,934)	2,998	(101)
Cash and cash equivalents, beginning of period	7,131	4,133	4,234
Cash and cash equivalents, end of period	5,197	7,131	4,133
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Distributions declared and unpaid	696	627	443
Common stock issued through the distribution reinvestment plan	9,563	6,421	5,482
Purchases of marketable securities not yet paid	79	97	52
Proceeds from sale of marketable securities not yet received	95	42	89
Proceeds from issuance of common stock not yet received	175	149	86
Redemption of common stock not yet paid	204	0	65
Extinguishment on note to affiliate	0	0	3,567
Discount on note to affiliate	0	0	236
Accrued offering costs not yet paid	3,509	3,767	4,973
Capital expenditures not yet paid	375	330	245
Supplemental Cash Flow Disclosures:
Interest paid	8,600	5,964	6,476
Real Estate and Related Assets
In connection with the purchase of investments in real estate and related assets, the Company also assumed certain non-real estate assets and liabilities:
Purchase price	0	128,639	0
Prepaid and other assets acquired	0	70	0
Other liabilities assumed	0	(800)	0
Investment in real estate and related assets	0	127,909	0
CMBS Trust
In connection with the purchase of investments in real estate and related assets, the Company also assumed certain non-real estate assets and liabilities:
Purchase price	1,157,636	0	0
Accrued interest receivable from real estate loans held in consolidated CMBS Trust	4,365	0	0
Bonds payable held in consolidated CMBS Trust, at fair value	(1,126,781)	0	0
Accrued interest payable on bonds held in consolidated CMBS Trust	(4,276)	0	0
Investment in real estate and related assets	$ 30,944	$ 0	$ 0